Protein A is a bacterial protein, which has capacity to bind mammalian antibodies of class immunoglobulin G with great affinity. Protein G binds to all subclasses of human immunoglobulin G (IgG) makes it useful for purifying polyclonal or monoclonal IgG antibodies whose subclasses have not been determined. Monoclonal antibodies are defined as ‘an antibody produced by a single clone of cells'. It can be used to carry drugs, toxins, or radioactive substances traditional to cancer cells. Monoclonal antibodies have been showing promising results in the management of chronic diseases such as cancers and rheumatoid arthritis. These are essential and are broadly used as purification and separation materials due to high resolution, across the biopharmaceutical industry. Natural protein A can be produced from Staphylococcus aureus, though protein A is now commonly produced recombinant in Escherichia coli. Chromatography with these has several advantages as a separation method, over conventional techniques such as solvent extraction, crystallization, and distillation.

Increasing diagnostic and therapeutic applications of monoclonal antibodies in management of chronic diseases such as cancer, rheumatoid arthritis beside with increasing R&D activities on monoclonal antibodies will drive protein A resins market over the forecast period. High selectivity and improved antibody production coupled with ease of operation in large and small scale antibody purification and immunoprecipitation will further drive growth of the protein A resins market growth. Encouraging government policies in terms of formulation of suitable policies for startups and administration of funding for development of next-gen medical products are expected to play a vital role in driving growth. Development of cost effective protein A resin is also expected to boost growth of the market.

Protein A Resin Market

On the basis of Product, the protein A resin market is classified into:

    • Natural Protein A Resin
    • Recombinant Protein A Resin

On the basis of Application, the protein A resin market is classified into:

    • Immunoprecipitation
    • Antibody Purification

On the basis of Matrix Type, the protein A resins is classified into:

    • Glass or Silica
    • Agarose and
    • Organic Polymer

On the basis of end users, the protein A resins is classified into:

    • Biopharmaceutical Manufacturers
    • Clinical Research Laboratories and
    • Academic Institutions

Geographically, North America accounted for the leading share in the global protein A resin market, due to the large number of clinical trials for the monoclonal antibody based therapeutics and increasing traction for biosimilars with the recent U.S. Food and Drugs Administration (FDA) in the region. The U.S. contributed largest revenue to the North American as well as global protein A resin industry. The country is expected to remain the largest market for protein A resin globally during the forecast period. This market is expected to witness the highest growth in Asia-Pacific during the forecast period, owing to the increasing compliance for biosimilars and shifting global attentiveness for expanding biopharmaceutical manufacturing capacities in the emerging economies of the region.

Increasing awareness about random methods to purify monoclonal antibodies is obstructing the Protein A Resins market. High costs associated with the Protein A resins is also a major factor restraining the market growth. Geographic expansion, agreements, strategic acquisitions, and continuous effort to improve the product assortment are the key strategies adopted by the market players to stand the competitive market.

There is an increasing demand for early detection and prevention of curable diseases especially in the adults. This is going to be a key opportunity in the market as the percentage of adult population is increasing on a daily basis owing to the rise in life expectancy among the global population. The demand for safe and valuable treatments is gaining prevalence in the market. This factor coupled with unmet medical needs among the patients will fuel the growth of the global sickle cell anemia therapeutics market.

Key players operating in the global protein A resin market are Thermo Fisher Scientific Inc., General Electric Company, Merck KGaA, Repligen Corporation, Tosoh Corporation, Expedeon Ltd., Novasep, and GenScript, among others.

Key Developments

  1. Key companies in the market are focused on various growth strategies such as product launches, in order to expand their product portfolio. For instance, in September 2017, GE Healthcare, a U.S.-based healthcare company, launched protein A chromatography resin. The company also announced to invest around U$ 70 million a year over each of the next five years to produce it.
  2. Key players in the market are involved in various growth strategies such as product launches, in order to expand their product portfolio. For instance, in June 2018, Purolite Life Sciences, a provider of pharmaceutical applications, launched new-generation protein A agarose resin ‘Praesto Jetted A50’. This new resin is a combination of jetting technology and high performance protein A ligand.
  3. Major companies in the market are involved in various business strategies such as partnership and collaboration, in order to enhance their market presence. For instance, in November 2017, Purolite Life Sciences collaborated with Repligen Collaboration, a life sciences company, to provide Purolite customers with end-to-end solutions for downstream purification of biologic drugs, particularly monoclonal antibody-based biologics.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.

Data Triangulation Methodology | Coherent Market Insights

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Market Analysis | Coherent Market Insights

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users